Bill
A 6222
Bill A 6222 protects 340B healthcare providers from discrimination, ensuring they can access and dispense affordable medications to patients effectively.
Bill A 6222, titled the "340B Prescription Drug Anti-Discrimination Act," was introduced on February 27, 2025, and is currently referred to the Health Committee. This legislation aims to address discrimination against healthcare providers participating in the 340B Drug Pricing Program, which allows eligible healthcare organizations to purchase medications at reduced prices.
The primary purpose of Bill A 6222 is to ensure that healthcare providers who participate in the 340B program are not discriminated against in their ability to provide prescription drugs to patients. The bill seeks to protect these providers from policies that may limit their access to necessary medications or impose unfair restrictions based on their participation in the program.
While the specific text of the bill is not provided, the following key provisions can be anticipated based on the bill's title and intent:
Anti-Discrimination Measures: The bill would likely establish legal protections for 340B providers against discriminatory practices by insurers, pharmacies, or other entities that may seek to limit their ability to dispense medications.
Access to Medications: It may include provisions that ensure 340B providers have equitable access to prescription drugs, thereby enabling them to serve their patient populations effectively.
Enforcement Mechanisms: The bill could outline procedures for reporting and addressing instances of discrimination, including potential penalties for non-compliance.
The following groups would be directly impacted by the provisions of Bill A 6222:
Healthcare Providers: Hospitals and clinics that participate in the 340B program would benefit from enhanced protections against discriminatory practices.
Patients: Individuals receiving care from 340B providers may experience improved access to affordable medications as a result of the bill's protections.
Insurers and Pharmacies: These entities may need to adjust their policies and practices to comply with the anti-discrimination measures established by the bill.
The bill is sponsored by Assembly Member Amy Paulin, with a significant number of cosponsors, including:
Bill A 6222 is related to prior session Bill A 7789 and has a companion bill in the Senate, S 1913, which may address similar issues regarding the 340B program.
This summary provides an overview of Bill A 6222, highlighting its purpose, key provisions, affected parties, and the current legislative status. As the bill progresses through the legislative process, further details may emerge that will clarify its specific impacts and requirements.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
